Apolipoprotein CIII and Atherosclerosis
- 12 August 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 118 (7), 702-704
- https://doi.org/10.1161/CIRCULATIONAHA.108.794081
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell DysfunctionCell Metabolism, 2008
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Interleukin-6 Impairs the Insulin Signaling Pathway, Promoting Production of Nitric Oxide in Human Umbilical Vein Endothelial CellsMolecular and Cellular Biology, 2007
- Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-αCirculation Research, 2007
- Apolipoprotein CIII-Induced THP-1 Cell Adhesion to Endothelial Cells Involves Pertussis Toxin-Sensitive G Protein- and Protein Kinase Cα-Mediated Nuclear Factor-κB ActivationArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial CellsCirculation, 2006
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemiaAtherosclerosis, 2004
- Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.JCI Insight, 1998